Neuphoria Therapeutics Inc. (NEUP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lynx1 Capital Management Weston Nichols | 875,228 | $3,395,885 | 0.69% | |
| 2. | Shay Capital Samuel Ginzburg | 169,059 | $655,949 | 0.07% | |
| 3. | Diadema Partners Timothy Beau Bassett | 50,000 | $194,000 | +134% | 0.03% |
| 4. | Ikarian Capital Neil Shahrestani | 47,443 | $184,079 | 0.01% | |
| 5. | ADAR1 Capital Management Daniel Schneeberger | 30,000 | $116,400 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.14 | 639,110 | $3,283,108.07 | 875,328 | 2025-10-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 134,194 | $520,673 | 0.09% | |
| 2. | 20,950 | $81,286 | 0% | |
| 3. | 17,303 | $67,135 | 0% | |
| 4. | 16,597 | $64,396 | 0% | |
| 5. | 14,750 | $57,230 | 0% |
Hedge Fund Resource Center Billionaire Hedge Funds
